You are on page 1of 2


Watanabe, Daisuke; Suzuma, Kiyosi; Suzuma, Izumi et. al. 2005. Vitreus Levels of Angiopentin
2 and Vascular Endothelial Growth Factor in Patients with Prolifferative Diabetic Retinopathy.
Departement of Opthalmology and Visual Science Kyoto University. Japan. Doi:
Pfister, Fredrick; Hagen, Fraziska Vom; Hoffman, Sigrid et. al. 2008. Pericyte Migration:
Anovel Mechanism of Pericyte Loss in Experimental Diabetic Retinopathy.Medical Research
Center, Medical Faculty Mannheim. Germany. Diabetes. 20008 Sep; 57 (9): 2495-502

Tarr, Joann M; Kaul, Kirti, Chopra Mohit et. al. 2013. Pathophysiology of Diabeitv Retinopathy.
In ISRN Opthalmology. UK
Preston, Gregory M; Calle Roberto A. 2010. Elevated Serum Sorbitol and Not Fructose in Type
2 Diabetic Patients. Pfizer Global Research and Development. USA
Brownle, Michael. 2001. Biochemistry and Molecular Cell Biologi of Diabetic Complications.
Departement of Medecine and pathology, and Diabetes and Training Center. USA
Khan, Zia A; Chakarabarti, Subrata. 2007. Cellular Signaling and Potential New Treatment
Targets in Diabetic Retinopathy. In experimental Diabetic Research Volume 2007. Doi:
Bhanuprakash, Reddy; Satyanaryana; Balakrishna 2008. Erythrocyte Aldose Reductase
Activity and Sorbitol Levels in Diabetic Retinopathy. In Molecular Vision 2008; 14:593-601.
National Institue of Nutrition, Biochemistry. India
Alghadyan, Abdulrahman. 2011. Diabetic Retinopathy. Department of Opthalmology Dammam
University. Saudi Arabia
Hallam, Kellie McCormick, Ananthakrishnan, Radha et. al. 2011. Aldose Reductase and AGERAGE Pathways: Central Roles in The Pathogenesis of Vascular Dysfunction in Aging Rats.
Department Of Surgery Columbia University. New York. Doi: 10.1111/j.14749726.2010.00606.x
Vriese, An s. De; Verbeuren, Tony J; Lameire, Norbert H. 2000. Endothelial Dysfunvtion in
Diabetes. Departement of Physiology Ghent University. Belgium
Srivastava, Satish K; Ramana, Kota V; Bhatanagar, Aruni. 2005. Role of Aldose Reductase and
Oxidative Damage in Diabetes and Consequent Potential for Therapeutic Options. Departement
of Human Biological Chemistry and Genetic. University of Texas Medical Branch. USA. Doi:

Alkatheri, Abdulmalik; Albeikary, Abdulkareem; Mansour, Mahmoud. 2013. Diabetic

Retinopathy: Its Progression and The Effective Treatment to Prevent Blindness. Science
Reuters.UK. doi: 10.5567/Pharmacologia. 2013.138.156

Ho, Shuk-mei; Tang, Wan-yee. 2007. Techniques Used in Studies of Epigenome Dysregulation
Due to Aberrant DNA Methylation: An Emphasis on Fetal Based Adult Disease. Departement
ofEnvironmental Health University of Cincinnati. USA. Reprod Toxicol. 2007; 23 (3): 267-282
Tewari, Shikha; Zhong, Qing; Santos, Julia M 2012. Mitochondria DNA Replication aand
DNA Methylation in The Metabolic Memory Associated with Continued Progression of Diabetic
Retinopathy. In investigative Opthalmology and Visual Science Vol. 53. No. 8. Wayne State
Nestor, E. Colm; Barrenas, Fredrick; Wang, Hui 2014.DNA Mehylation Changes Separate
Allergic Patients From Healty Controls and May Reflect Altered CD4+ T-Cell Population
Structure. Plos Genetic Vol. 10. E1004059. Swenden,
Tao, Jia; Liu, Qi; Wu, Xiaohou 2013. Identificattion of Hypermethylation in Hepatocyte
Cell Adhesion Molecule Gene Promoter Region in Bladder Carcinoma. Department of
Laboratory Diagnosis Chngqing Medical University. China
Zhong, Qing; Kowluru, Renu A. 2012. Epigenetic Modification of Sod2 in The Development of
Diabetic Retinopathy and in The Metabolic Memory: Role Of Histone Methylation. In
investigative Opthalomolgy and Visual Science Vol. 54, No. 1. Wayne State University. Detroit